Numerous studies have shown the impact of increased expression of inflammatory mediators on the increase in the expression of IDO and TDO, cerebral 5-HT deficiencies, and the characteristic behavioral patterns in the form of cognitive (deteriorating memory function) and emotional (depression, anxiety) deficits [4,55]. This evidence concerns the gene IDO1 and depressive symptom measurement.